Cyanvac Llc

This early-stage trial is testing two new mumps vaccines given as a nasal spray, called CVM150 and CVM26, in up to 60 healthy adults aged 18-29. The main goal is to check if they are safe and to see how well they trigger an immune response. Unlike traditional shots, these vaccine…

This study tests a single-dose nasal spray COVID-19 vaccine (CVXGA) against a standard mRNA shot in about 432 healthy adults who have already had a primary COVID-19 vaccine series. The goal is to see if the nasal vaccine is safer and better at preventing symptomatic COVID-19 over…

This study tests a new COVID-19 vaccine given as a nasal spray. It aims to see if the spray is safe and helps the body fight the virus. About 227 healthy adults aged 18 to 80 will take part. The vaccine is designed to boost immunity in the nose, where the virus often enters.